
Differences and Temporal Changes in Risk of Invasive Pneumococcal Disease in Adults with Hematological Malignancies: Results from a Nationwide 16-Year Cohort Study
Author(s) -
Michael Asger Andersen,
Carsten Utoft Niemann,
Klaus Rostgaard,
Tine Dalby,
Rasmus Sørrig,
Daniel M Weinberger,
Henrik Hjalgrim,
Zitta Barrella Harboe
Publication year - 2020
Publication title -
clinical infectious diseases/clinical infectious diseases (online. university of chicago. press)
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/ciaa090
Subject(s) - medicine , population , multiple myeloma , incidence (geometry) , cancer , poisson regression , pediatrics , confidence interval , cohort , acute lymphocytic leukemia , vaccination , chronic lymphocytic leukemia , leukemia , immunology , lymphoblastic leukemia , physics , environmental health , optics
Patients with hematological malignancies (HM) are known to carry an increased risk of invasive pneumococcal disease (IPD). However, temporal variations in IPD risks following a cancer diagnosis remain poorly characterized. To inform vaccine guidelines and patient management, we assessed the IPD incidence among patients with HM and other malignancies.